Aetiology of autoimmune diseases
Immune regulation defect in MG
Genetic factors in autoimmune MG: present status and challenges
Role of AIRE deficiency in thymoma-MG
Thymic changes in MG patients
Cytokine production of B-cell culture of MG patients
Dok-7, Musk, and the development of the neuromuscular junction
The role of AChR associated proteins in autoimmune MG
Pathogenic mechanisms underlying synaptic dysfunction in congenital myasthenic syndromes
Identification of a mutation in agrin that causes congenital myasthenia and affects synapse function
Anti-AChR antibodies increase IL-6 production by myoblasts and myotubes in vitro
Therapeutic approaches for MG studied in animal models
Complement-targeted therapy for MG
Mobilization of regulatory immune cells utilizing GM-CSF in EAMG
Cholinergic anti-inflammatory signaling through α7 nicotinic acetylcholine receptor
Development of safe and effective oral tolerogen for MG
An update on diagnosis issues
Recombinant antigenic domains for the study, diagnosis and treatment of MG
Status of the Trial for Thymectomy in nonthymomatous MG Patients Receiving Prednisone (MGTX)
Mycophenolate Mofetil (MMF) in AChR-antibody Positive MG: Outcomes in 102 patients
Refractory MG and rituximab: long term follow-up of three patients and the “FORCE” trial
Classifying seronegative MG: a population based study
Myasthenia Gravis: from functioning and disability evaluation towards new healthcare approaches
Long-term treatment in MG: A review
MG in the elderly
A questionnaire for assessing the impact of socio-economic factors in MG
The EuroMyasthenia project: What has it brought to the MG community?
Clinical and serological analysis of 175 patients with MG in Hungary
Session dedicated to interactions between clinicians, scientists and patients